Botulinum Toxin Market Share, Size, and Outlook by 2031
Botulinum Toxin Market: Strategic Insights
Botulinum Toxin Market
-
CAGR (2023 - 2031)12.6% -
Market Size 2023
US$ 7.38 Billion -
Market Size 2031
US$ 19.03 Billion
Market Dynamics
GROWTH DRIVERS
- Rising Popularity of Noninvasive Aesthetics Procedures
- Increasing Use of Botulinum Toxin for Enhancing Facial Aesthetics
FUTURE TRENDS
- Expanding Therapeutic Applications
OPPORTUNITIES
- Rising Adoption Aesthetic Procedure in Emerging Economies
Key Players
- AbbVie Inc
- Merz Pharma
- Medytox
- Ipsen Pharma
- Galderma
- Revance Therapeutics Inc
- Lanzhou Institute of Biological Products Co Ltd
- Evolus Inc
- Hugel Inc
- Aquavit
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Botulinum Toxin A
- Botulinum Toxin B
Application
- Medical
- Aesthetic
End User
- Speciality and Dermatology Clinics
- Hospitals and Clinics